Global Insulin Delivery Systems Market 2016-2020

Global insulin delivery systems market forecast

According to the insulin delivery systems market analysis, the global insulin delivery systems market is estimated to witness significant growth and will post a CAGR of more than 5% over the forecast period. The paradigm shift of patients from hospitals to specialty clinics is one of the key factors aiding in the insulin delivery systems market growth. In the past, the treatment for diabetes was popular in hospitals where an endocrinologist or a dietician would guide patients in type-1 diabetes management. However, due to the limited visiting slots and high consultation fees, the patients look for alternatives. Recently, some clinics have started to focus only on type-1 and type-2 diabetes management due to which the concept of exclusive specialty clinics centers evolved. As a result, the waiting time of patients has significantly reduced and the availability of medication and delivery systems at the attached pharmacy stores has increased. Also, these centers provide additional benefits like health insurance cards, which allow patients to avail discounts on bills and obtain insulin delivery devices at a relatively lower price. Most of the countries like the US, Canada, India, and Japan have specialty clinics for diabetes management.

According to this market study, the Americas is expected to lead the market with a total market share of over 80% by 2020. North America held the largest market share and is expected to maintain its dominant position during the forecast period. According to the Pan American Health Organization (PAHO) in 2015, health expenditures for diabetes in the Americas will increase by approximately USD 445 billion over the years as the cost of health care for people affected by diabetes is high. This will lead to the use of insulin delivery devices at higher rates among type-1 diabetes population. Several companies are venturing into this market due to which devices like insulin jet injectors and insulin pumps have better penetration into Mexican and Brazilian markets. Moreover, the support from the government has increased over the years, thus, ensuring deeper penetration of insulin delivery devices.

Competitive landscape and key vendors

The level of competition in the global insulin delivery systems market is intense as vendors are offering different insulin delivery devices at competitive prices. Furthermore, to have a strong hold over the market, most vendors are adopting strategies like tie-ups with hospitals and specialty diabetic clinics, online marketing, and home services. These strategies also help vendors to expand their product portfolio. Major players like Novo Nordisk, Sanofi, Eli Lilly, BD, and Medtronic are focusing on enhancing their global and regional presence through M&A and operational expansion. The vendors are also expanding their sales operations in the emerging markets such as India and China to gain high market shares.

Key vendors in the market are 

• Novo Nordisk
• Sanofi
• Eli Lilly
• Medtronic
• Becton Dickinson

Other prominent vendors in the market are Animas, Beta Bionics, Cellnovo, Copernicus, Dance Biopharm, Debiotech, InsuJet, Insulet, MannKind, Owen Mumford, Roche, SHL Group, SOOIL, Valeritas, West Pharma, and Ypsomed.

Product segmentation and analysis of the insulin delivery systems market

• Insulin syringes
• Insulin pump
• Insulin pens
• Insulin jet injectors

According to this market study, the insulin pen segment is anticipated to dominate the market and will account for more than 58% of the total market share by 2020. Insulin pens are the next level of diagnostic devices and are highly user-friendly compared to syringes. Though the cost of insulin pens is higher, they have a good market share in North American countries like the United States and Canada. The governments in APAC countries like Australia and Japan have started introducing these devices under patient reimbursement policies. Furthermore, the R&D cost will increase in the future as there is stiff competition between insulin device manufacturers, which, in turn, would lead to the launch of innovative products in the market.

Segmentation by end user and analysis of the insulin delivery systems market

• Hospitals
• Specialty diabetic clinics
• Retail channels

In this market research, the hospitals are the key end users that greatly influence market growth. Multi-specialty hospitals and hospital groups work under government sponsorship or through private entities, offering a large number of inpatient and outpatient services and generate more revenues. These hospitals work closely with many suppliers, reimbursement authorities, and government organizations in order to procure the delivery of insulin devices.

Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the global insulin delivery systems market?
• What are the key market trends impacting the growth of the global insulin delivery systems market?
• What are the challenges to market growth?
• Who are the key vendors in the global insulin delivery systems market?
• What are the market opportunities and threats faced by the vendors in the global software license management insulin delivery systems market?
• Trending factors influencing the market shares in the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of the global insulin delivery systems market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

• Insulin Market in the US and Europe 2016-2020
• Insulin Market in Europe 2015-2019
• Global Human Insulin Market 2015-2019
• Global Self-Care Medical Devices Market 2016-2020